United Therapeutics CFO to Present at Jefferies Healthcare Conference

  • United Therapeutics CFO James Edgemond to present company overview on June 3, 2026.
  • Presentation scheduled for 12:45–1:15 PM EST at Jefferies Global Healthcare Conference in New York.
  • Live webcast available on United Therapeutics' investor relations website.
  • Archived recording accessible for 90 days post-event.

United Therapeutics' presentation comes amid a broader industry shift toward innovative solutions for rare diseases and organ transplantation. As a public benefit corporation, the company faces unique governance dynamics while navigating competitive pressures in the biotech sector. Investors will be watching for updates on its financial performance and R&D pipeline.

Strategic Priorities
How United Therapeutics will balance rare disease treatments with organ manufacturing initiatives.
Financial Performance
Whether the company can sustain revenue growth amid competitive pressures in the biotech sector.
Execution Risk
The pace at which United Therapeutics advances its organ manufacturing technology.